Parnassus Investments LLC lessened its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 17.8% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,604,052 shares of the company’s stock after selling 565,367 shares during the quarter. Parnassus Investments LLC’s holdings in Procter & Gamble were worth $373,187,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. raised its position in shares of Procter & Gamble by 1,000.0% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock worth $25,000 after buying an additional 150 shares in the last quarter. Park Square Financial Group LLC boosted its holdings in shares of Procter & Gamble by 65.1% in the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock worth $26,000 after purchasing an additional 71 shares in the last quarter. Evolution Wealth Management Inc. increased its position in shares of Procter & Gamble by 1,315.4% during the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after purchasing an additional 171 shares during the last quarter. Maseco LLP purchased a new position in shares of Procter & Gamble during the 4th quarter valued at about $28,000. Finally, Saranac Partners Ltd purchased a new position in shares of Procter & Gamble during the 3rd quarter valued at about $30,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Down 0.4%
PG stock opened at $148.50 on Friday. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The business’s 50 day moving average price is $144.53 and its two-hundred day moving average price is $147.69. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73. The company has a market capitalization of $345.80 billion, a price-to-earnings ratio of 21.71, a price-to-earnings-growth ratio of 6.48 and a beta of 0.39.
Procter & Gamble Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Friday, April 24th were given a $1.0885 dividend. The ex-dividend date of this dividend was Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.9%. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s payout ratio is presently 63.60%.
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Commentary from investors and media continues to describe PG as a durable, dividend-oriented consumer staples name with steady cash flow, reinforcing the stock’s appeal as a defensive holding. Is The Procter & Gamble Company (PG) A Good Stock To Buy Now?
- Positive Sentiment: Jim Cramer highlighted P&G as one of the kinds of stocks that can help investors “safely own the techs,” reinforcing its role as a stable portfolio anchor during market volatility. Jim Cramer Says “The P&Gs and the J&Js in Your Portfolio Allow You to Safely Own the Techs”
- Positive Sentiment: P&G and OLAY announced virtual companion technology for skincare simulations, showing continued innovation in higher-engagement beauty and personal care products. Haut.AI Collaborates with OLAY on Virtual Companion Technology to Power Clinically Modeled Skincare Simulations
- Positive Sentiment: Brokerage coverage cited in a recent note showed PG still carrying an average “Moderate Buy” rating, which supports sentiment around the shares. Procter & Gamble Company (The) (NYSE:PG) Given Average Rating of “Moderate Buy” by Brokerages
- Neutral Sentiment: P&G and the American Academy of Family Physicians released an oral-health survey for Crest and Oral-B, mainly serving as a brand-marketing update rather than a clear earnings catalyst. New Survey from P&G and American Academy of Family Physicians Reveals 76% of Americans Say They Care About Their Oral Health, But When Polled, Only 3% of Americans Associate Oral Health with Whole Body Health
- Neutral Sentiment: PG also presented at the Evercore Consumer & Retail Conference, but the transcript headline alone does not indicate a major new financial surprise. The Procter and Gamble Company (PG) Presents at The 6th Annual Evercore Consumer and Retail Conference Transcript
- Negative Sentiment: Investors are also weighing restructuring news, including a leadership reshuffle and plans to cut more than 3,500 jobs globally, which could raise execution and transition concerns in the near term. Procter And Gamble Restructuring And Leadership Shift Create Valuation Watchpoints
Analysts Set New Price Targets
A number of brokerages have commented on PG. JPMorgan Chase & Co. reduced their price target on shares of Procter & Gamble from $165.00 to $162.00 and set an “overweight” rating on the stock in a research report on Friday, April 17th. Piper Sandler upped their price objective on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Friday, April 24th. BNP Paribas Exane reduced their target price on shares of Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating on the stock in a report on Thursday, April 23rd. Rothschild & Co Redburn lowered their price target on shares of Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating for the company in a research note on Monday, April 27th. Finally, The Goldman Sachs Group lowered their price target on shares of Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating for the company in a research note on Wednesday, April 8th. Eleven research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $160.78.
Get Our Latest Research Report on PG
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
